Our study also suggests that targeting Twist could inhibit the interaction between TGF-β and Wnt pathways that could not only prevent breast cancer progressing to EMT and enhancing sensitivity of cancer treatment, but could also inhibit the TGF-β- and Wnt3-induced MMPs and VEGF. The gene discussed is TWIST1; the disease is breast cancer.